HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emilia Bevacqua Selected Research

Dextrans (Dextran)

6/2021Dextran-Curcumin Nanosystems Inhibit Cell Growth and Migration Regulating the Epithelial to Mesenchymal Transition in Prostate Cancer Cells.
12/2019Dextran-Curcumin Nanoparticles as a Methotrexate Delivery Vehicle: A Step Forward in Breast Cancer Combination Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emilia Bevacqua Research Topics

Disease

3Prostatic Neoplasms (Prostate Cancer)
07/2023 - 06/2021
2Inflammation (Inflammations)
07/2023 - 01/2023
2Neoplasms (Cancer)
12/2021 - 06/2021
1Carcinogenesis
07/2023
1Medulloblastoma
12/2021
1Breast Neoplasms (Breast Cancer)
12/2019

Drug/Important Bio-Agent (IBA)

3CurcuminIBA
07/2023 - 12/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 06/2021
2MicroRNAs (MicroRNA)IBA
11/2022 - 12/2021
2Dextrans (Dextran)FDA Link
06/2021 - 12/2019
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2023
1QuercetinIBA
07/2023
1CytokinesIBA
07/2023
1PolyphenolsIBA
07/2023
1AntioxidantsIBA
07/2023
1Biomarkers (Surrogate Marker)IBA
11/2022
1RNA (Ribonucleic Acid)IBA
12/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2021
1EnzymesIBA
12/2019
1Methotrexate (Mexate)FDA LinkGeneric
12/2019
1LaccaseIBA
12/2019

Therapy/Procedure

2Therapeutics
06/2021 - 12/2019